atrasentan has been researched along with Fetal Growth Restriction in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alexander, BT; Intapad, S; Ojeda, NB; Royals, TP; Varney, E | 1 |
| Dewey, ER; Neerhof, MG; Thaete, LG | 1 |
2 other study(ies) available for atrasentan and Fetal Growth Restriction
| Article | Year |
|---|---|
Sex-Specific Effect of Endothelin in the Blood Pressure Response to Acute Angiotensin II in Growth-Restricted Rats.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Atrasentan; Blood Pressure; Blotting, Western; Enalapril; Endothelin Receptor Antagonists; Endothelin-1; Female; Fetal Growth Retardation; Glomerular Filtration Rate; Hemodynamics; Kidney; Male; Ovariectomy; Pregnancy; Pyrrolidines; Rats; Receptor, Endothelin A; Receptor, Endothelin B; Reverse Transcriptase Polymerase Chain Reaction; Sex Factors | 2015 |
Endothelin and the regulation of uterine and placental perfusion in hypoxia-induced fetal growth restriction.
Topics: Animals; Atrasentan; Blood Flow Velocity; Blood Pressure; Cobalt Radioisotopes; Endothelin A Receptor Antagonists; Endothelin-1; Female; Fetal Growth Retardation; Fetal Hypoxia; Fetus; Gestational Age; Kidney; Microspheres; Oxygen; Placenta; Pregnancy; Pyrrolidines; Rats; Rats, Sprague-Dawley; Uterus | 2004 |